A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin

Aim. To improve diagnosis and treatment of patients with coronary artery disease and obesity. Material and methods. New onset diabetes mellitus in patient with coronary artery disease and comorbid obesity 6 months after atorvastatin treatment was described. Results and Discussion. In our obser...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: T.A. Maksymets, O.O. Bondarenko, Y.Y. Skliarov
Formato: article
Lenguaje:EN
UK
Publicado: Danylo Halytsky Lviv National Medical University 2018
Materias:
Acceso en línea:https://doaj.org/article/6a7cb10d971b4ab29470126aed0a89f5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a7cb10d971b4ab29470126aed0a89f5
record_format dspace
spelling oai:doaj.org-article:6a7cb10d971b4ab29470126aed0a89f52021-11-10T19:50:04ZA clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin1029-42442415-330310.25040/aml2018.01.074https://doaj.org/article/6a7cb10d971b4ab29470126aed0a89f52018-02-01T00:00:00Zhttps://amljournal.com/index.php/journal/article/view/129https://doaj.org/toc/1029-4244https://doaj.org/toc/2415-3303Aim. To improve diagnosis and treatment of patients with coronary artery disease and obesity. Material and methods. New onset diabetes mellitus in patient with coronary artery disease and comorbid obesity 6 months after atorvastatin treatment was described. Results and Discussion. In our observation, the patient K. as of 11.07.16 was diagnosed with: Сoronary artery disease, Stable angina pectoris III, post-infarction (08.04.2016) cardiosclerosis. Planned stenting of of the second branch of the right coronary artery with stenosis of 99%. 17.05.16. Stage 1 hypertension, degree III, risk 4 (very high). Hypertensive heart. Heart failure IIA with preserved ejection fraction. Obesity class I, abdominal type. The patient had initial disorders of the glucose metabolism, such as hyperglycemia, insulin resistance, hyperleptinemia, and decreased omentine levels. The patient was treated with atorvastatin 40 mg according to treatment guidelines. New onset diabetes mellitus in the patient was diagnosed six months later and Metformin 500 mg was prescribed. Thus, as a result of timely diagnosed type 2 diabetes, it was possible to prescribe necessary treatment and avoid complications. Conclusion. Patients with coronary artery disease and obesity are at increased risk of developing type 2 diabetes, which requires more medical attention and glucose metabolism monitoring.T.A. MaksymetsO.O. BondarenkoY.Y. SkliarovDanylo Halytsky Lviv National Medical Universityarticlecoronary artery disease, insulin resistance, оbesity, diabetes mellitus type 2, atorvastatinMedicine (General)R5-920ENUKActa Medica Leopoliensia, Vol 24, Iss 1, Pp 74-76 (2018)
institution DOAJ
collection DOAJ
language EN
UK
topic coronary artery disease, insulin resistance, оbesity, diabetes mellitus type 2, atorvastatin
Medicine (General)
R5-920
spellingShingle coronary artery disease, insulin resistance, оbesity, diabetes mellitus type 2, atorvastatin
Medicine (General)
R5-920
T.A. Maksymets
O.O. Bondarenko
Y.Y. Skliarov
A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
description Aim. To improve diagnosis and treatment of patients with coronary artery disease and obesity. Material and methods. New onset diabetes mellitus in patient with coronary artery disease and comorbid obesity 6 months after atorvastatin treatment was described. Results and Discussion. In our observation, the patient K. as of 11.07.16 was diagnosed with: Сoronary artery disease, Stable angina pectoris III, post-infarction (08.04.2016) cardiosclerosis. Planned stenting of of the second branch of the right coronary artery with stenosis of 99%. 17.05.16. Stage 1 hypertension, degree III, risk 4 (very high). Hypertensive heart. Heart failure IIA with preserved ejection fraction. Obesity class I, abdominal type. The patient had initial disorders of the glucose metabolism, such as hyperglycemia, insulin resistance, hyperleptinemia, and decreased omentine levels. The patient was treated with atorvastatin 40 mg according to treatment guidelines. New onset diabetes mellitus in the patient was diagnosed six months later and Metformin 500 mg was prescribed. Thus, as a result of timely diagnosed type 2 diabetes, it was possible to prescribe necessary treatment and avoid complications. Conclusion. Patients with coronary artery disease and obesity are at increased risk of developing type 2 diabetes, which requires more medical attention and glucose metabolism monitoring.
format article
author T.A. Maksymets
O.O. Bondarenko
Y.Y. Skliarov
author_facet T.A. Maksymets
O.O. Bondarenko
Y.Y. Skliarov
author_sort T.A. Maksymets
title A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
title_short A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
title_full A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
title_fullStr A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
title_full_unstemmed A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
title_sort clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
publisher Danylo Halytsky Lviv National Medical University
publishDate 2018
url https://doaj.org/article/6a7cb10d971b4ab29470126aed0a89f5
work_keys_str_mv AT tamaksymets aclinicalcaseofnewonsettype2diabetesmellitusinapatientwithcoronaryarterydiseaseandobesitytreatedwithatorvastatin
AT oobondarenko aclinicalcaseofnewonsettype2diabetesmellitusinapatientwithcoronaryarterydiseaseandobesitytreatedwithatorvastatin
AT yyskliarov aclinicalcaseofnewonsettype2diabetesmellitusinapatientwithcoronaryarterydiseaseandobesitytreatedwithatorvastatin
AT tamaksymets clinicalcaseofnewonsettype2diabetesmellitusinapatientwithcoronaryarterydiseaseandobesitytreatedwithatorvastatin
AT oobondarenko clinicalcaseofnewonsettype2diabetesmellitusinapatientwithcoronaryarterydiseaseandobesitytreatedwithatorvastatin
AT yyskliarov clinicalcaseofnewonsettype2diabetesmellitusinapatientwithcoronaryarterydiseaseandobesitytreatedwithatorvastatin
_version_ 1718439680626655232